168 related articles for article (PubMed ID: 14726538)
1. Intestinal tumor progression is associated with altered function of KLF5.
Bateman NW; Tan D; Pestell RG; Black JD; Black AR
J Biol Chem; 2004 Mar; 279(13):12093-101. PubMed ID: 14726538
[TBL] [Abstract][Full Text] [Related]
2. Krüppel-like factor 5 mediates the transforming activity of oncogenic H-Ras.
Nandan MO; Yoon HS; Zhao W; Ouko LA; Chanchevalap S; Yang VW
Oncogene; 2004 Apr; 23(19):3404-13. PubMed ID: 15077182
[TBL] [Abstract][Full Text] [Related]
3. Inducible intestine-specific deletion of Krüppel-like factor 5 is characterized by a regenerative response in adult mouse colon.
Nandan MO; Ghaleb AM; Liu Y; Bialkowska AB; McConnell BB; Shroyer KR; Robine S; Yang VW
Dev Biol; 2014 Mar; 387(2):191-202. PubMed ID: 24440658
[TBL] [Abstract][Full Text] [Related]
4. KLF5/BTEB2, a Krüppel-like zinc-finger type transcription factor, mediates both smooth muscle cell activation and cardiac hypertrophy.
Nagai R; Shindo T; Manabe I; Suzuki T; Kurabayashi M
Adv Exp Med Biol; 2003; 538():57-65; discussion 66. PubMed ID: 15098654
[TBL] [Abstract][Full Text] [Related]
5. Krüppel-like factor 5 is a crucial mediator of intestinal tumorigenesis in mice harboring combined ApcMin and KRASV12 mutations.
Nandan MO; Ghaleb AM; McConnell BB; Patel NV; Robine S; Yang VW
Mol Cancer; 2010 Mar; 9():63. PubMed ID: 20298593
[TBL] [Abstract][Full Text] [Related]
6. PPARgamma agonists inhibit cell growth and suppress the expression of cyclin D1 and EGF-like growth factors in ras-transformed rat intestinal epithelial cells.
Kitamura S; Miyazaki Y; Hiraoka S; Nagasawa Y; Toyota M; Takakura R; Kiyohara T; Shinomura Y; Matsuzawa Y
Int J Cancer; 2001 Nov; 94(3):335-42. PubMed ID: 11745411
[TBL] [Abstract][Full Text] [Related]
7. Haploinsufficiency of Krüppel-like factor 5 rescues the tumor-initiating effect of the Apc(Min) mutation in the intestine.
McConnell BB; Bialkowska AB; Nandan MO; Ghaleb AM; Gordon FJ; Yang VW
Cancer Res; 2009 May; 69(10):4125-33. PubMed ID: 19435907
[TBL] [Abstract][Full Text] [Related]
8. Krüppel-like factor 5 promotes mitosis by activating the cyclin B1/Cdc2 complex during oncogenic Ras-mediated transformation.
Nandan MO; Chanchevalap S; Dalton WB; Yang VW
FEBS Lett; 2005 Aug; 579(21):4757-62. PubMed ID: 16102754
[TBL] [Abstract][Full Text] [Related]
9. KLF5 promotes cell proliferation and tumorigenesis through gene regulation and the TSU-Pr1 human bladder cancer cell line.
Chen C; Benjamin MS; Sun X; Otto KB; Guo P; Dong XY; Bao Y; Zhou Z; Cheng X; Simons JW; Dong JT
Int J Cancer; 2006 Mar; 118(6):1346-55. PubMed ID: 16184550
[TBL] [Abstract][Full Text] [Related]
10. Decreased transforming growth factor beta type II receptor expression in intestinal adenomas from Min/+ mice is associated with increased cyclin D1 and cyclin-dependent kinase 4 expression.
Zhang T; Nanney LB; Peeler MO; Williams CS; Lamps L; Heppner KJ; DuBois RN; Beauchamp RD
Cancer Res; 1997 May; 57(9):1638-43. PubMed ID: 9134999
[TBL] [Abstract][Full Text] [Related]
11. Krüppel-like factor 5 is important for maintenance of crypt architecture and barrier function in mouse intestine.
McConnell BB; Kim SS; Yu K; Ghaleb AM; Takeda N; Manabe I; Nusrat A; Nagai R; Yang VW
Gastroenterology; 2011 Oct; 141(4):1302-13, 1313.e1-6. PubMed ID: 21763241
[TBL] [Abstract][Full Text] [Related]
12. Intestinal-enriched Krüppel-like factor (Krüppel-like factor 5) is a positive regulator of cellular proliferation.
Sun R; Chen X; Yang VW
J Biol Chem; 2001 Mar; 276(10):6897-900. PubMed ID: 11152667
[TBL] [Abstract][Full Text] [Related]
13. Krüppel-like factor 5 mediates cellular transformation during oncogenic KRAS-induced intestinal tumorigenesis.
Nandan MO; McConnell BB; Ghaleb AM; Bialkowska AB; Sheng H; Shao J; Babbin BA; Robine S; Yang VW
Gastroenterology; 2008 Jan; 134(1):120-30. PubMed ID: 18054006
[TBL] [Abstract][Full Text] [Related]
14. Haploinsufficiency of Krüppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis.
Ghaleb AM; McConnell BB; Nandan MO; Katz JP; Kaestner KH; Yang VW
Cancer Res; 2007 Aug; 67(15):7147-54. PubMed ID: 17671182
[TBL] [Abstract][Full Text] [Related]
15. Reduction of menin expression enhances cell proliferation and is tumorigenic in intestinal epithelial cells.
Ratineau C; Bernard C; Poncet G; Blanc M; Josso C; Fontanière S; Calender A; Chayvialle JA; Zhang CX; Roche C
J Biol Chem; 2004 Jun; 279(23):24477-84. PubMed ID: 15054094
[TBL] [Abstract][Full Text] [Related]
16. Stromal Indian hedgehog signaling is required for intestinal adenoma formation in mice.
Büller NV; Rosekrans SL; Metcalfe C; Heijmans J; van Dop WA; Fessler E; Jansen M; Ahn C; Vermeulen JL; Westendorp BF; Robanus-Maandag EC; Offerhaus GJ; Medema JP; D'Haens GR; Wildenberg ME; de Sauvage FJ; Muncan V; van den Brink GR
Gastroenterology; 2015 Jan; 148(1):170-180.e6. PubMed ID: 25307863
[TBL] [Abstract][Full Text] [Related]
17. Human Kruppel-like factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells.
Chen C; Sun X; Guo P; Dong XY; Sethi P; Cheng X; Zhou J; Ling J; Simons JW; Lingrel JB; Dong JT
J Biol Chem; 2005 Dec; 280(50):41553-61. PubMed ID: 16223724
[TBL] [Abstract][Full Text] [Related]
18. Downregulation and growth inhibitory effect of epithelial-type Krüppel-like transcription factor KLF4, but not KLF5, in bladder cancer.
Ohnishi S; Ohnami S; Laub F; Aoki K; Suzuki K; Kanai Y; Haga K; Asaka M; Ramirez F; Yoshida T
Biochem Biophys Res Commun; 2003 Aug; 308(2):251-6. PubMed ID: 12901861
[TBL] [Abstract][Full Text] [Related]
19. Concurrent overexpression of cyclin D1 and cyclin-dependent kinase 4 (Cdk4) in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients.
Zhang T; Nanney LB; Luongo C; Lamps L; Heppner KJ; DuBois RN; Beauchamp RD
Cancer Res; 1997 Jan; 57(1):169-75. PubMed ID: 8988060
[TBL] [Abstract][Full Text] [Related]
20. Krüppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation.
Oishi Y; Manabe I; Tobe K; Tsushima K; Shindo T; Fujiu K; Nishimura G; Maemura K; Yamauchi T; Kubota N; Suzuki R; Kitamura T; Akira S; Kadowaki T; Nagai R
Cell Metab; 2005 Jan; 1(1):27-39. PubMed ID: 16054042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
